The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Myocardial Infarct–Sparing Effect of Adenosine A2AReceptor Activation Is due to Its Action on CD4+T Lymphocytes
Abstract
Background—We previously used adenosine A 2A receptor (A2AR) knockout (KO) mice and bone marrow transplantation to show that the infarct-sparing effect of A2AR activation at reperfusion is primarily due to effects on bone marrow–derived cells. In this study we show that CD4+but not CD8+T lymphocytes contribute to myocardial ischemia/reperfusion injury. Method and Results—After a 45-minute occlusion of the left anterior descending coronary artery and reperfusion, T cells accumulate in the infarct zone within 2 minutes. Addition of 10 μg/kg of the A2AR agonist ATL146e 5 minutes before reperfusion produces a significant reduction in T-cell accumulation and a significant reduction in infarct size (percentage of risk area) measured at 24 hours. In Rag1 KO mice lacking mature lymphocytes, infarct size is significantly smaller than in C57BL/6 mice. Infarct size in Rag1 KO mice is increased to the level of B6 mice by adoptive transfer of 50 million CD4+T lymphocytes derived from C57BL/6 or A2AR KO but not interferon-γ KO mice. ATL146e completely blocked the increase in infarct size in Rag1 KO mice reconstituted with B6 but not A2AR KO CD4+T cells. The number of neutrophils in the reperfused heart at 24 hours after infarction correlated well with the number of lymphocytes and infarct size. Conclusions—These results strongly suggest that the infarct-sparing effect of A2AR activation is primarily due to inhibition of CD4+T-cell accumulation and activation in the reperfused heart.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ohta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell Clones
Salgame, P., Abrams, J. S., Clayberger, C., Goldstein, H., Convit, J., Modlin, R. L., & Bloom, B. R. (1991) · Science · doi:10.1126/science.1681588 · Cited by 1,028
A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells
Lappas, C. M., Rieger, J. M., & Linden, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1073 · Cited by 385
Self-citationCytokine mRNA expression in postischemic/reperfused myocardium.
Herskowitz, A., Choi, S. J., Ansari, A. A., & Wesselingh, S. L. (1995) · Europe PMC (PubMed Central) · Cited by 374
CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.
Zwacka, R. M., Zhang, Y., Halldorson, J., Schlossberg, H., Dudus, L., & Engelhardt, J. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119533 · Cited by 365
Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice
Rabb, H., Daniels, F., O'Donnell, M., Haq, M., Saba, S. R., Keane, W., & Tang, W. W. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f525 · Cited by 352
Loetscher, P., Seitz, M., Lewis, I. C., Baggiolini, M., & Moser, B. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.13.7926371 · Cited by 323
Entman, M. L., Youker, K., Shoji, T., Kukielka, G., Shappell, S. B., Taylor, A. A., & Smith, C. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115999 · Cited by 300
Cutting Edge: T Helper 1 and T Helper 2 Cells Respond Differentially to Chemokines
Siveke, J. T., & Hamann, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.550 · Cited by 257
Adenosine in Tissue Protection and Tissue Regeneration
Linden, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011783 · Cited by 234
Self-citation
Cited by
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,301
Self-citationAdenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
Self-citationThe IL-33/ST2 pathway: therapeutic target and novel biomarker
Kakkar, R., & Lee, R. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2660 · Cited by 794
Purinergic regulation of the immune system
Cekic, C., & Linden, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.4 · Cited by 787
Self-citationPharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Metadata
- Authors
- Yang, Z., Day, Y.-J., Toufektsian, M.-C., Xu, Y., Ramos, S. I., Marshall, M. A., French, B. A., & Linden, J.
- Venue
- Circulation
- Published
- 2006-11-07
- Volume
- 114
- Issue
- 19
- Pages
- 2056-2064
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2171946189
- Cited by
- 283
- References
- 29
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myocardial Infarct–Sparing Effect of Adenosine A2AReceptor Activation Is due to Its Action on CD4+T Lymphocytes. https://app.cochat.ai/papers/10.1161/circulationaha.106.649244
- The paper
- Yang, Z., Day, Y.-J., Toufektsian, M.-C., Xu, Y., Ramos, S. I., Marshall, M. A., French, B. A., & Linden, J. (2006). Myocardial Infarct–Sparing Effect of Adenosine A2AReceptor Activation Is due to Its Action on CD4+T Lymphocytes. Circulation. https://doi.org/10.1161/circulationaha.106.649244
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.